Grünenthal Enhances Genetic Medicine Expertise by Joining the Munich Cluster for Nucleic Acid Therapeutics

Grünenthal Joins Munich-based Cluster for Nucleic Acid Therapeutics Aachen, Germany – Grünenthal, a global leader in pain management and related diseases, announced today its official partnership with the Cluster for Nucleic Acid Therapeutics Munich (CNATM) on Thursday, July 16, 2026. This collaboration will bring together leading universities, research institutions, biotech companies…

Source

Grünenthal Enhances Genetic Medicine Expertise by Joining the Munich Cluster for Nucleic Acid Therapeutics

SpaceX slips below IPO price as UK investors’ £271m bet turns sour

The £4.8bn India deal is the starting gun, not the prize

The £4.8bn India deal is the starting gun, not the prize

Pibit.AI raises $7m Series A to bring trusted AI underwriting to the insurance sector

Gold Prices Rise as the Dollar Slowly Dies

Richard Murphy, The Bank of England, And MMT Confusion

We Can’t Fix International Organizations like the WTO. Abolish Them.

Economic Foundations and Christianity Are Compatible

Ana-Maria Coaching Marks Milestone with New Book Release

New Bonded Warehouse Facilities Launched in Immingham

From Corporate Burnout to High-Performance Coach: Anna Mosley’s Inspiring Journey with ‘Eighty’

Economic Foundations and Christianity Are Compatible

England’s semi-final gives pubs their biggest night of the World Cup

Rule out a wealth tax or own the exodus, Burnham warned

Whitehall’s AI playbook: train staff first, switch on tools second

Recent News

Economic Foundations and Christianity Are Compatible

England’s semi-final gives pubs their biggest night of the World Cup

Rule out a wealth tax or own the exodus, Burnham warned

Whitehall’s AI playbook: train staff first, switch on tools second